CryoLife VP Jeffrey Burris Sells 5,000 Shares (CRY)
CryoLife (NYSE:CRY) VP Jeffrey Burris sold 5,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $9.00, for a total transaction of $45,000.00. Following the completion of the transaction, the vice president now directly owns 79,099 shares in the company, valued at approximately $711,891. The transaction was disclosed in a document filed with the SEC, which is available at this link.
CryoLife (NYSE:CRY) remained flat at $8.99 during during mid-day trading trading on Thursday. 153,610 shares of the company’s stock traded hands. CryoLife has a 1-year low of $5.52 and a 1-year high of $7.80. The stock has a 50-day moving average of $7.32 and a 200-day moving average of $6.66. The company has a market cap of $248.3 million and a price-to-earnings ratio of 33.30.
CryoLife (NYSE:CRY) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.07. The company had revenue of $36.30 million for the quarter, compared to the consensus estimate of $35.51 million. During the same quarter last year, the company posted $0.08 earnings per share. CryoLife’s revenue was up 8.7% compared to the same quarter last year. Analysts expect that CryoLife will post $0.37 EPS for the current fiscal year.
Separately, analysts at Zacks upgraded shares of CryoLife from a “neutral” rating to an “outperform” rating in a research note to investors on Wednesday. They now have a $9.40 price target on the stock.
CryoLife, Inc (NYSE:CRY) is a biological medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.